246 related articles for article (PubMed ID: 18787443)
1. Thromboprophylaxis in medical-surgical critically ill patients.
Crowther MA; Cook DJ
Curr Opin Crit Care; 2008 Oct; 14(5):520-3. PubMed ID: 18787443
[TBL] [Abstract][Full Text] [Related]
2. Thromboprophylaxis in the intensive care unit: focus on medical-surgical patients.
Cook DJ; Crowther MA
Crit Care Med; 2010 Feb; 38(2 Suppl):S76-82. PubMed ID: 20083918
[TBL] [Abstract][Full Text] [Related]
3. Preventing venous thromboembolism in critically ill patients.
Crowther MA; Cook DJ
Semin Thromb Hemost; 2008 Jul; 34(5):469-74. PubMed ID: 18956287
[TBL] [Abstract][Full Text] [Related]
4. [The prophylaxis against venous thromboembolic complications in internal medicine--the gap between theory and practice].
Hirmerová J
Vnitr Lek; 2006 Apr; 52(4):379-88. PubMed ID: 16755994
[TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients.
McGarry LJ; Thompson D; Weinstein MC; Goldhaber SZ
Am J Manag Care; 2004 Sep; 10(9):632-42. PubMed ID: 15515996
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of venous thromboembolism in internal medicine and neurology].
Malý J; Dulícek P; Penka M; Malý R; Gumulec J
Vnitr Lek; 2006 Mar; 52 Suppl 1():63-7. PubMed ID: 16637452
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism in critical illness in a community intensive care unit.
Muscedere JG; Heyland DK; Cook D
J Crit Care; 2007 Dec; 22(4):285-9. PubMed ID: 18086398
[TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolism prophylaxis in medical patients: future perspectives.
Imberti D; Prisco D
Thromb Res; 2005; 116(5):365-75. PubMed ID: 16122549
[TBL] [Abstract][Full Text] [Related]
9. Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency.
Rabbat CG; Cook DJ; Crowther MA; McDonald E; Clarke F; Meade MO; Lee KA; Cook RJ
J Crit Care; 2005 Dec; 20(4):357-63. PubMed ID: 16310608
[TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolism prophylaxis in the critically ill: a point prevalence survey of current practice in Australian and New Zealand intensive care units.
Robertson MS; Nichol AD; Higgins AM; Bailey MJ; Presneill JJ; Cooper DJ; Webb SA; McArthur C; MacIsaac CM; ;
Crit Care Resusc; 2010 Mar; 12(1):9-15. PubMed ID: 20196708
[TBL] [Abstract][Full Text] [Related]
11. [Thrombosis prophylaxis with heparins in intensive care patients].
Greinacher A; Janssen D
Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Mar; 40(3):156-63. PubMed ID: 15770559
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials.
Wein L; Wein S; Haas SJ; Shaw J; Krum H
Arch Intern Med; 2007 Jul; 167(14):1476-86. PubMed ID: 17646601
[TBL] [Abstract][Full Text] [Related]
13. Prevention of venous thromboembolism.
Pini M; Spyropoulos AC
Semin Thromb Hemost; 2006 Nov; 32(8):755-66. PubMed ID: 17171588
[TBL] [Abstract][Full Text] [Related]
14. A retrospective study on the use of a low-molecular-weight heparin for thromboembolism prophylaxis in large-volume liposuction and body contouring procedures.
Newall G; Ruiz-Razura A; Mentz HA; Patronella CK; Ibarra FR; Zarak A
Aesthetic Plast Surg; 2006; 30(1):86-95; discussion 96-7. PubMed ID: 16404651
[TBL] [Abstract][Full Text] [Related]
15. Thromboprophylaxis for intensive care patients in Australia and New Zealand: a brief survey report.
Cooper DJ; Bishop N; Cade J; Finfer S; Gallus A; Myburgh J;
J Crit Care; 2005 Dec; 20(4):354-6. PubMed ID: 16310607
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT study.
Douketis J; Cook D; Meade M; Guyatt G; Geerts W; Skrobik Y; Albert M; Granton J; Hébert P; Pagliarello G; Marshall J; Fowler R; Freitag A; Rabbat C; Anderson D; Zytaruk N; Heels-Ansdell D; Crowther M;
Arch Intern Med; 2008 Sep; 168(16):1805-12. PubMed ID: 18779469
[TBL] [Abstract][Full Text] [Related]
17. Antifactor Xa activity in critically ill patients receiving antithrombotic prophylaxis with standard dosages of certoparin: a prospective, clinical study.
Jochberger S; Mayr V; Luckner G; Fries DR; Mayr AJ; Friesenecker BE; Lorenz I; Hasibeder WR; Ulmer H; Schobersberger W; Dünser MW
Crit Care; 2005 Oct; 9(5):R541-8. PubMed ID: 16277716
[TBL] [Abstract][Full Text] [Related]
18. PROphylaxis for ThromboEmbolism in Critical Care Trial protocol and analysis plan.
Cook D; Meade M; Guyatt G; Walter SD; Heels-Ansdell D; Geerts W; Warkentin TE; Cooper DJ; Zytaruk N; Vallance S; Berwanger O; Rocha M; Qushmaq I; Crowther M
J Crit Care; 2011 Apr; 26(2):223.e1-9. PubMed ID: 21482348
[TBL] [Abstract][Full Text] [Related]
19. Venous thromboembolism prophylaxis and treatment in patients with acute stroke and traumatic brain injury.
Vergouwen MD; Roos YB; Kamphuisen PW
Curr Opin Crit Care; 2008 Apr; 14(2):149-55. PubMed ID: 18388676
[TBL] [Abstract][Full Text] [Related]
20. Malignancy and venous thrombosis in the critical care patient.
Wu C; Lee AY
Crit Care Med; 2010 Feb; 38(2 Suppl):S64-70. PubMed ID: 20083916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
